Company Profiles

driven by the PitchBook Platform

Esperance Pharmaceuticals

Description

Provider of therapeutic services for cancer. The company engages in the development of anticancer drugs that selectively kill cancer cells without harming normal cells.

2005

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$40M

Latest Deal Amount

$64M

Total Amount Raised

Description

Provider of therapeutic services for cancer. The company engages in the development of anticancer drugs that selectively kill cancer cells without harming normal cells.

Website:

www.esperancepharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

909 Fannin Street Suite 2000 Houston, TX 77010United States +1 (610) 291-0307
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Esperance Pharmaceuticals's full profile, request a free trial.

Esperance Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Esperance Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Esperance Pharmaceuticals Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Advantage Capital PartnersVenture CapitalMinority000 0000000 0000
BVM CapitalVenture CapitalMinority000 0000000 0000
Louisiana FundVenture CapitalMinority000 0000000 0000
Research Corporation TechnologiesVenture CapitalMinority000 0000000 0000
Sanofi-Genzyme BioventuresCorporate Venture CapitalMinority000 0000000 0000
Advantage Capital Partners Venture Capital
BVM Capital Venture Capital
Louisiana Fund Venture Capital
Research Corporation Technologies Venture Capital
Sanofi-Genzyme Bioventures Corporate Venture Capital

Esperance Pharmaceuticals Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Melany AdamcioDirector, Clinical Operations
Hector Alila Ph.DFounder, Chief Executive Officer, President and Board Member
Carola LeuschnerVice President, Research & Development
Clarice MotterInterim Chief Financial Officer & Controller
Joseph LovettChairman
Melany Adamcio Director, Clinical Operations
Hector Alila Ph.D Founder, Chief Executive Officer, President and Board Member
Carola Leuschner Vice President, Research & Development
Clarice Motter Interim Chief Financial Officer & Controller
Joseph Lovett Chairman

Esperance Pharmaceuticals Board Members (4)

NameRepresentingRoleSinceContact
Info
Brett Giroir MDEsperance PharmaceuticalsBoard Member000 0000
Hector Alila Ph.DEsperance PharmaceuticalsFounder, Chief Executive Officer, President and Board Member000 0000
Joseph LovettSelfChairman000 0000
Ross Barrett JDBVM CapitalGeneral Partner & Co-Founder000 0000
Brett Giroir MD Board Member Esperance Pharmaceuticals
Hector Alila Ph.D Founder, Chief Executive Officer, President and Board Member Esperance Pharmaceuticals
Joseph Lovett Chairman Self
Ross Barrett JD General Partner & Co-Founder BVM Capital
Request full access to PitchBook